Market Snapshot

BSE Sensex: 84559.65 -0.14%
BSE 500: 36870.7 -0.31%
BSE 200: 11646.71 -0.25%
BSE 100: 27017.07 -0.20%
BSE MidCap: 45946.26 -0.53%
BSE SmallCap: 50313.35 -0.85%
BSE BANKEX: 65970.79 -0.08%
BSE IT: 36859.64 0.21%
Nifty 50: 25818.55 -0.16%
Nifty 500: 23496.05 -0.31%
Nifty 200: 14331.25 -0.26%
Nifty 100: 26342.65 -0.20%
Nifty Midcap 100: 59388.85 -0.54%
Nifty Small 100: 17138.55 -0.73%
Nifty IT: 38172.05 0.29%
Nifty PSU Bank: 8318.3 1.29%

News:

Indian Overseas Bank ends shar...
V.L. Infraprojects JV bags Rs ...
Vikram Solar board clears Rs 4...
NBCC (India) secures orders wo...
Akzo Nobel India Ltd leads los...

Hester Biosciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

17 Dec 2025 | 03:59 PM

1,599.00

20.40 (1.29%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-33.78%

Return (1Y)

Underperformed BSE Healthcare by 32.84%
More Volatile

2.81%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.84%
Not so consistent

4/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

2,490

1,247

News & Announcements

Hester Biosciences appoints Ashish Desai as CFO
27 days ago

Hester Biosciences appoints Ashish Desai as CFO

20 - Nov - 2025 12:00 | 27 days ago

Ashish Desai, Group Finance Controller at Hester Biosciences, is a Chartered Accountant with over 25 years of experience in accounting, finance, auditing, costing, and taxation. He has driven key initiatives in financial restructuring, treasury management, trade finance, and cost optimization, while strengthening systems and internal controls. Before joining Hester, he served as CFO at Blue Ray Aviation and previously held senior finance roles at Shreeyam Power & Steel Industries and other organizations.
Hester Biosciences is one of the leading animal health care companies & the second-largest poultry vaccine manufacturer in India.
The company's consolidated net profit surged 76.2% to Rs 14.45 crore on a 15.2% drop in revenue from operations to Rs 70.97 crore in Q2 FY26 over Q2 FY25.
Shares of Hester Biosciences rose 0.59% to Rs 1,672 on the BSE.
Powered by Capital Market - Live News
Hester Biosciences appoints Ashish Desai as CFO
27 days ago

Hester Biosciences appoints Ashish Desai as CFO

20 - Nov - 2025 12:00 | 27 days ago

Hester Biosciences announced the appointment of Ashish Desai as Chief Financial Officer and Key Managerial Personnel of the Company (categorised as Senior Management Personnel), presently serving as Group Finance Controller will assume the role of Chief Financial Officer of the Company with effect from 20 November 2025.
Powered by Capital Market - Live News
Hester Biosciences consolidated net profit rises 76.22% in the September 2025 quarter
35 days ago

Hester Biosciences consolidated net profit rises 76.22% in the September 2025 quarter

12 - Nov - 2025 12:00 | 35 days ago

Net profit of Hester Biosciences rose 76.22% to Rs 14.45 crore in the quarter ended September 2025 as against Rs 8.20 crore during the previous quarter ended September 2024. Sales declined 15.20% to Rs 70.97 crore in the quarter ended September 2025 as against Rs 83.69 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 70.97 83.69 -15

OPM % 16.51 22.89 -

PBDT 21.39 16.07 33

PBT 17.04 11.87 44

NP 14.45 8.20 76

Powered by Capital Market - Live News
Hester Biosciences announces board meeting date
42 days ago

Hester Biosciences announces board meeting date

05 - Nov - 2025 12:00 | 42 days ago

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 12 November 2025.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Hester Biosciences Ltd has increased by 1117.47% since past 3 Months
FII shareholding in Hester Biosciences Ltd has decreased by -12.77% since past 1 Year
MF shareholding in Hester Biosciences Ltd has increased by 38.46% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	70.97	83.69	-15
OPM %	16.51	22.89	-
PBDT	21.39	16.07	33
PBT	17.04	11.87	44
NP	14.45	8.20	76

General Notifications

My Notifications

Research Notifications

Hester Biosciences Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

1,599.00 20.40 (1.29%)

News & Announcements

Price vs Volume

Stock Trivia

Hester Biosciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

1,599.00

20.40 (1.29%)